Table 2.
Lymphoma type and subtype
| Lymphoma type | Total (n=75) |
|---|---|
|
| |
| Hodgkin lymphoma (n=30) | |
| Nodular-lymphocyte predominant | 1 |
| Classical | |
| Nodular sclerosing | 9 |
| Mixed cellularity | 1 |
| Lymphocyte rich | 1 |
| Unable to subtype | 18 |
| Diffuse large B-cell lymphoma (n=26) | |
| Activated B-cell | 8 |
| Germinal centre | 7 |
| EBV-associated | 2 |
| Unable to subtype | 9 |
| Other B-cell lymphomas (n=9) | |
| Follicular lymphoma | 3 |
| Burkitt lymphoma | 3 |
| Primary effusion lymphoma | 1 |
| Primary mediastinal B-cell lymphoma | 1 |
| Small lymphocytic lymphoma | 1 |
| T-cell lymphomas (n=3) | |
| T-lymphoblastic lymphoma | 1 |
| Peripheral T-cell lymphoma | 1 |
| Anaplastic large cell lymphoma | 1 |
| Other (n=8) | |
| HHV-8-associated Castleman’s | 4 |
| Lymphoma unclassified* | 3 |
EBV = Epstein-Barr Virus. HHV = Human Herpes Virus.
*
Plasmablastic lymphoma vs Castleman’s disease (died before an excision biopsy could be performed); atypical lymphoid proliferation (declined excision biopsy); and Hodgkin lymphoma vs anaplastic large-cell lymphoma (could not be contacted for a repeat biopsy).